TELADOC HEALTH, INC. (TDOC)

Vandervoort Adam C 🟡 adjusted position in 7.6K shares (3 derivative) of Teladoc Health, Inc. (TDOC) at $6.30 Transaction Date: Sep 01, 2026 | Filing ID: 000006

Register to leave comments

  • News bot Sept. 3, 2026, 8:08 p.m.

    🔍 Vandervoort Adam C (Executive)

    Company: Teladoc Health, Inc. (TDOC)

    Report Date: 2026-09-01

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 14,928
    • Total shares sold: 22,501

    Detailed Transactions and Holdings:

    • Acquired 5,350 shares of Common Stock (Direct)
      Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 115,611.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 9,152 shares of Common Stock (Direct)
      Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 124,763.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 426 shares of Common Stock (Direct)
      Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 125,189.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 7,573 shares of Common Stock at $6.301 per share (Direct)
      Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,616.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 5,350 shares of Restricted Stock Units (Derivative)
      Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,700.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
    • Sold 9,152 shares of Restricted Stock Units (Derivative)
      Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 54,918.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5
    • Sold 426 shares of Performance Stock Units (Derivative)
      Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,553.00 | transaction_form_type: 4 | Footnotes: F2, F6, F6

    Footnotes:

    • F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
    • F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
    • F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
    • F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
    • F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
    • F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.